UAE-Based The Black Box Announces Project Pipeline Exceeding USD 10 Million Following Participation at Make it in the Emirates 2026 
Lerner & Rowe Gives Back to Host 5th Annual Cornhole Tournament on May 9 in Crown Point, Indiana 
Sagtec Global Limited Strengthens Smart Property Development Collaboration Following Stateight Sdn Bhd’s Industry Recognition 
TruMerit and Credivera Issue First Verifiable Digital Credentials for Global Healthcare Professionals 
MK International Achieves ASEAN & Asia Records for Proprietary Quantum Molecular Technology Spray Series Top Tier Marketing Academy Offers Third Party Resource Support and Training
The advanced marketing education institution is pleased to announce that it provides comprehensive support and…
Bryan Punturo Collaborates on a New Article
The owner and proprietor of Traverse City, Michigan’s ParkShore Resort lent his expertise to an…
Relief Reports Successful Conclusion of Patent Examination Procedure for Patent Application Entitled, ‘Vasoactive Intestinal Peptide (VIP) for the Use in the Treatment of Drug-induced Pneumonitis’
GENEVA, SWITZERLAND / ACCESSWIRE / December 28, 2021 / RELIEF THERAPEUTICS Holding SA (SIX:RLF)(OTCQB:RLFTF)(OTCQB:RLFTY) (“Relief“),…
CORRECTION: Li-Metal Raises Over $19 Million from the Exercise of Share Purchase Warrants
(This release corrects the release that was posted on December 24, 2021, which incorrectly stated…
EverGrow New Cryptocurrency That Could 100X in 2022
NEWARK, DE / ACCESSWIRE / December 27, 2021 / EverGrow, a newly launched crypto, is…
On substantial participation (4) – specified
On December 27th, 2021 JSC Olainfarm has received specified announcement on substantial participation from AS…
Sosei Heptares to present at 40th Annual J.P. Morgan Healthcare Conference
TOKYO, Japan and LONDON, Dec. 28, 2021 (GLOBE NEWSWIRE) — Sosei Group Corporation (“the Company”;…
Nykode Therapeutics announces first subject dosed with its T cell focused next-generation SARS-CoV-2 vaccine candidate
First subject dosed with Nykode Therapeutics’ T cell focused SARS-CoV-2 vaccine candidate. This is part…
Burning Rock Announces Results of 2021 Annual General Meeting
GUANGZHOU, China, Dec. 27, 2021 (GLOBE NEWSWIRE) — Burning Rock Biotech Limited (NASDAQ: BNR, the…
Eledon Pharmaceuticals to Participate in January 2022 Investor Conferences
IRVINE, Calif., Dec. 27, 2021 (GLOBE NEWSWIRE) — Eledon Pharmaceuticals, Inc. (“Eledon”) (NASDAQ: ELDN), a…
Infant Bacterial Therapeutics today announces new patent protection approvals in Brazil and in Hong Kong
Infant Bacterial Therapeutics AB today announces that the Patent Offices of Brazil and Hong Kong…
Sorrento Announces COVISTIX COVID-19 Virus Rapid Antigen Detection Test Detects the Omicron Variant
COVISTIX maintains its ability to detect the Omicron Variant, in addition to detecting SARS-CoV-2 and…
Todos Medical Records Record Weekly COVID PCR Testing Volumes at Provista
cPass neutralizing antibody testing seeing increasing demand, questions of infection-acquired immunity, vaccine-acquired immunity and booster…
Sorrento Therapeutics Mexico Executes Second Contract for Sale of 10 Million COVISTIX Tests for Mexico Market
SAN DIEGO and MEXICO CITY, Dec. 27, 2021 (GLOBE NEWSWIRE) — Sorrento Therapeutics, Inc. (Nasdaq:…
Castellum Announces Signing of LOI to Acquire $4 Million Government Contractor
Castellum Announces Signing of LOI to Acquire $4 million government contractor Castellum, Inc. (OTC: ONOV)…
Faraday Pharmaceuticals Announces Publication of Results from its Phase 2 Study of FDY-5301 for the Treatment of Reperfusion Injury Following a STEMI Heart Attack
To be Published in the International Journal of Cardiology SEATTLE, Dec. 27, 2021 (GLOBE NEWSWIRE)…
Revolo Biotherapeutics Announces the Appointment of Tunde Otulana, M.D., to its Board of Directors
NEW ORLEANS and LONDON, Dec. 27, 2021 (GLOBE NEWSWIRE) — Revolo Biotherapeutics (“Revolo Bio” or…
TRACON Pharmaceuticals Announces Positive Results from the Independent Data Monitoring Committee Review of Interim Safety and Efficacy Data from the Ongoing ENVASARC Pivotal Trial
Pre-specified Interim Analysis Concluded with Recommendation to Continue the ENVASARC Trial Objective Response Rate (ORR)…
Celularity Receives Fast Track Designation from U.S. FDA for its NK Cell Therapy CYNK-001 in Development for the Treatment of AML
FLORHAM PARK, N.J., Dec. 27, 2021 (GLOBE NEWSWIRE) — Celularity Inc. (Nasdaq: CELU) (“Celularity”), a…
Aclaris Therapeutics to Participate in the H.C. Wainwright BioConnect Virtual Conference
WAYNE, Pa., Dec. 27, 2021 (GLOBE NEWSWIRE) — Aclaris Therapeutics, Inc. (NASDAQ: ACRS), a clinical-stage…